Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil

Virology Journal

Volumn 9, Issue , 2012, Pages

  Alcalde, Rosana ^a   Guimarães, Monick L ^b   Duarte, Alberto J S ^a   Casseb, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Brazil; HIV 1; Recombinants; Resistance; S o Paulo; Subtypes

Indexed keywords

RNA;

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; MALE; MOLECULAR BIOLOGY; NONHUMAN; PHYLOGENY; RNA EXTRACTION; VIRUS RECOMBINANT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; FEMALE; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; REASSORTANT VIRUSES; RNA, VIRAL; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864708814     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-156     Document Type: Article

References (48)

1. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. Aghokeng AF, Vergne L, Mpoudi-Ngole E, Mbangue M, Deoudje N, Mokondji E, Nambei WS, Peyou-Ndi MM, Moka JJL, Delaporte E, Peeters M, Antivir Ther 2009 14 401 411 19474474
2. Identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. Kim JE, Beckthold B, Chen Z, Mihowich J, Malloch L, Gill MJ, AIDS Res Hum Retrovir 2007 23 11 1309 1313 10.1089/aid.2007.0080 18184071
3. Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. Peeters M, Aghokeng AF, Delaporte E, Clin Microbiol Infect 2010 16 1525 1531 10.1111/j.1469-0691.2010.03300.x 20649800
4. HIV-1 diversity: a tool for studying the pandemic. Pinto ME, Struchiner CJ, Cad Saúde Pública 2006 22 3 473 484 23016718 (Pubitemid 43677869)
5. Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA, J Int AIDS Soc 2009 12 1 11 10.1186/1758-2652-12-1 19900280
6. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Tscherning C, Alaeus A, Fredriksson R, Björndal A, Deng H, Littman DR, Fenyö EM, Albert J, Virology 1998 241 181 188 10.1006/viro.1997.8980 9499793 (Pubitemid 28384191)
7. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow MM, Eron JJ, Fiscus SA, Cohen MS, Swanstrom R, J Virol 1999 73 6271 6281 10400718 (Pubitemid 29327803)
8. High replication fitness and transmission efficiency of HIV-1 subtype C from India: implications for subtype C predominance. Rodriguez MA, Ding M, Ratner D, Chen Y, Tripathy SP, Kulkarni SS, Chatterjee R, Tarwater PM, Gupta P, Virology 2009 385 416 424 10.1016/j.virol.2008.12.025 19157481
9. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. Arin KK, Abraha A, Quĩones-Mateu ME, Kestens L, Vanham G, Arts EJ, J Virol 2005 79 14 8979 8990 10.1128/JVI.79.14.8979-8990.2005 15994792 (Pubitemid 40934809)
10. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. Sucupira MCA, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Shafer KP, Diaz RS, AIDS Patient Care STDs 2007 21 2 116 128 10.1089/apc.2006.0079 17328661 (Pubitemid 46394455)
11. HIV-1 subtypes: epidemiology and significance for HIV management. Geretti AM, Curr Opin Infect Dis 2006 19 1 1 7 10.1097/01.qco.0000200293.45532.68 16374210 (Pubitemid 43032432)
12. Global trends in molecular epidemiology of HIV-1 during 2000-2007. Hemelaar J, Gouws E, Ghys PD, Osmanov S, WHO-UNAIDS Network for HIV Isolation and Characterisation, AIDS 2011 25 5 679 689 10.1097/QAD.0b013e328342ff93 21297424
13. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. Hemelaar J, Gouws E, Ghys PD, Osmanov S, AIDS 2006 20 16 13 W23 10.1097/01.aids.0000247564.73009.bc 17053344 (Pubitemid 44611051)
14. Understanding the genetic diversity of HIV-1. McCutchan FE, AIDS 2000 14 Suppl 3 31 S44 11086847
15. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B) recombinant strain in China. Su L, Graf M, Zhang Y, Briesen HV, Xing H, Kostler J, Melzl H, Wolf H, Shao Y, Wagner R, J Virol 2000 74 23 11367 11376 10.1128/JVI.74.23.11367-11376.2000 11070037 (Pubitemid 32224007)
16. Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. Santos AF, Sousa TM, Soares EAJM, Sanabani S, Martinez AMB, Sprinz E, Silveira J, Sabino EC, Tanuri A, Soares MA, AIDS 2006 20 16 2011 2019 17053347 (Pubitemid 44611054)
17. A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. Koulinska IN, Ndungu T, Mwakagile D, Msamanga G, Kagoma C, Fawzi W, Essex M, Renjifo B, AIDS Res Hum Retrovir 2001 17 5 423 431 10.1089/088922201750102508 11282011 (Pubitemid 32506934)
18. The Circulating Recombinant Forms (CRFs) Los Alamos National Laboratory web site, http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html, accessed 25 May 2011
19. Whats new in HIV/AIDS HIV genetic diversity: any implications for drug resistance? Jülg B, Goebel FD, Infection 2005 33 299 301 10.1007/s15010-005-6405-1 16091906 (Pubitemid 41152196)
20. HIV subtype, epidemiological and mutational correlations in patients from Paraná, Brazil. Silva MM, Telles FQ, da Cunha CA, Rhame FS, Braz J Infect Dis 2010 14 5 495 501 21221479
21. Brazilian network for HIV drug resistance surveillance (HIV-BResNet): a survey of chronically infected individuals. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A, Brazilian Network for Drug Resistance Surveillance, AIDS 2003 17 7 1063 1069 10.1097/00002030-200305020-00016 12700457 (Pubitemid 36549719)
22. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Rodrigues R, Scherer LC, Oliveira CM, Franco HM, Sperhacke RD, Ferreira JL, Castro SM, Stella IM, Brigido LF, Virus Res 2006 116 1-2 201 207 16332398 (Pubitemid 43221733)
23. HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. Brígido LF, Nunes CC, Oliveira CM, Knoll RK, Ferreira JL, Freitas CA, Alves MA, Dias C, Rodrigues R, Research Capacity Program, AIDS Res Hum Retrovir 2007 23 1579 1586 10.1089/aid.2007.0102 18160017
24. HIV-1 subtype C in Brazil. Csillag C, Lancet 1994 344 1354 7968035
25. HIV-1 subtypes among intravenous drug users from two neighboring cities in São Paulo State, Brazil. Rossini MAA, Diaz RS, Caseiro M, Turcato G, Accetturi CA, Sabino EC, Braz J Med Biol Res 2001 34 45 47 10.1590/S0100- 879X2001000100005 11151027 (Pubitemid 33605444)
26. Southern Brazil HIV type 1 C expansion into the state of São Paulo, Brazil. Brigido LFM, Ferreira JLP, Almeida VC, Rocha SQ, Ragazzo TG, Estevam DL, Rodrigues R, for the São Paulo HIV Salvage Workgroup, AIDS Res Hum Retrovir 2011 27 339 344 10.1089/aid.2010.0157 20950149
27. HIV type 1 antiretroviral resistance mutations in subtypes B, C, and F in the City of São Paulo, Brazil. Munerato P, Sucupira MC, Oliveros MPR, Janini LM, de Souza DF, Pereira AA, Inocencio LA, Diaz RS, AIDS Res Hum Retrovir 2010 26 3 265 273 10.1089/aid.2008.0288 20210652
28. Short communication: molecular characterization of HIV type 1 BF pol recombinants from São Paulo, Brazil. de Souza AC, de Oliveira CM, Rodrigues CL, Silva SA, Levi JE, AIDS Res Hum Retrovir 2008 24 1521 1525 10.1089/aid.2008.0089 19025398
29. National Program on STD/AIDS, Brazilian Ministry of Health, Brazil. National Network of Laboratories for Genotyping-AIDS (http://www.aids.gov.br)
30. Drug resistance among chronic HIV-1-infected patients nave for use of anti-retroviral therapy in Sao Paulo city. Gonsalez CR, Alcalde R, Nishiya A, Barreto C, Silva FES, Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJS, Virus Res 2007 129 2 87 90 10.1016/j.virusres.2007.06.021 17686543 (Pubitemid 47595356)
31. HIV/AIDS. Gonsalez CR, Alcalde R, HIV resistance to ARVs: implications for new therapeutic options Atheneu: LIM/HC/FMUSP, Casseb J, 2010 71 83
32. Stanford University online HIV Drug Resistance Database web site, (http://www.hivdb.Stanford.edu/index.html)
33. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA Panel. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD, Clin Infect Dis 2008 47 266 285 10.1086/589297 18549313 (Pubitemid 351920631)
34. Update of the drug resistance mutations in HIV-1: Spring 2008. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD, Top HIV Med 2008 16 1 62 68 18441382
35. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, Kuritzkes DR, Bennett D, AIDS 2007 21 2 215 223 10.1097/QAD.0b013e328011e691 17197813 (Pubitemid 46036930)
36. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, Nucleic Acids Res 1997 25 24 4876 4882 10.1093/nar/25.24.4876 9396791 (Pubitemid 28022245)
37. Some probabilistic and statistical problems in the analysis of DNA sequences. American Mathematical Society. Tavaré S, Lect Math Life Sci 1986 17 57 86
38. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Tamura K, Dudley J, Nei M, Kumar S, Mol Biol Evol 2007 24 1596 1599 10.1093/molbev/msm092 17488738 (Pubitemid 47236692)
39. jModelTest: phylogenetic model averaging. Posada D, Mol Biol Evol 2008 25 1253 1256 10.1093/molbev/msn083 18397919 (Pubitemid 351882013)
40. MrBayes 3: Bayesian phylogenetic inference under mixed models. Ronquist F, Huelsenbeck JP, Bioinform Appl Note 2003 19 12 1572 1574 (Pubitemid 37038874)
41. Ray S, Simplot v3.5.1 2009 Available from: http://www.med.jhu.edu/ deptmed/sray/download/
42. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. Kimura M, J Mol Evol 1980 16 2 111 120 10.1007/BF01731581 7463489 (Pubitemid 11166431)
43. Application of phylogenetic networks in evolutionary studies. Huson DH, Bryant D, Mol Biol Evol 2006 23 2 254 267 16221896 (Pubitemid 43100040)
44. In-depth analysis of the origins of HIV type 1 subtype C in South America. Jones LR, Dilernia DA, Manrique JM, Moretti F, Salomon H, Carrillo MG, AIDS Res Hum Retrovir 2009 25 10 951 959 10.1089/aid.2008.0293 19842791
45. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the Inland North State of Tocantins, Brazil. Carvalho BC, Cardoso LPV, Damasceno S, Stefani MMA, AIDS Res Hum Retrovir 2011 27 1 7 10.1089/aid.2010.0156 20860535
46. Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique. Abreu CM, Brindeiro PA, Martins NA, Arruda MB, Bule E, Stakteas S, Tanuri A, Brindeiro RM, Arch Virol 2008 153 11 2013 2017 10.1007/s00705-008-0215-6 18839058
47. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against non-nucleoside inhibitors of RT. Loemba H, Brenner B, Parniak MA, Maayan S, Spira B, Moisi D, Oliveira M, Detorio M, Wainberg MA, Antimicrob Agents Chemother 2002 46 7 2087 2094 10.1128/AAC.46.7.2087-2094.2002 12069959 (Pubitemid 34665901)
48. A V106M mutation in HIV-1 clade C viruses exposed to efavirens confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, Marlink RG, Schapiro J, Roger M, Wainberg MA, AIDS 2003 17 1 1 F5 10.1097/00002030-200301030-00001 12478089 (Pubitemid 36106291)